AMBER BERNELIS: Open Payments
NPI 1912481284 · YREKA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$120 in 7 payments from 4 companies in 2025. Trend: 2023 $33 · 2024 $117 · 2025 $120
Food & beverage: $120
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $17 |
Products named: INGREZZA, REXULTI, FANAPT, ARISTADA.
Industry payments across CA — which companies pay providers there.
